JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1985; 6:556-563
© 1985 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson,
Right arrow Articles by Ferraro, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, , JR
Right arrow Articles by Ferraro, N

Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failure

Wilson JR and N Ferraro

The maximal aerobic exercise capacity of patients with chronic heart failure is frequently decreased because of inadequate blood flow to working skeletal muscle. To investigate whether this reduced flow is in part due to interference by angiotensin II with arteriolar dilation in working muscle, the effect of the angiotensin-converting enzyme inhibitor captopril on leg blood flow, leg vascular resistance, leg oxygen consumption (VO2) and leg lactate release during maximal upright bicycle exercise was examined in 12 patients with heart failure (maximal VO2 10.7 +/- 3.1 ml/min per kg). Captopril decreased leg resistance at rest (258 +/- 115 to 173 +/- 67 U, p less than 0.01) and maximal exercise (68 +/- 69 to 45 +/- 29 U, p less than 0.01) associated with proportionately similar decreases in systemic vascular resistance. However, maximal exercise duration and maximal VO2 were unchanged and, at identical peak exercise work times, there was no improvement in leg blood flow (2.0 +/- 0.9 to 2.0 +/- 1.1 liters/min, p = NS), leg VO2 (261 +/- 104 to 281 +/- 157 ml/min, p = NS) or leg lactate release (269 +/- 149 to 227 +/- 151 mg/min, p = NS). These data suggest that, during exercise in patients with heart failure, angiotensin II does not interfere with blood flow to working skeletal muscle.


This article has been cited by other articles:


Home page
 CirculationHome page
I. L. Pina, C. S. Apstein, G. J. Balady, R. Belardinelli, B. R. Chaitman, B. D. Duscha, B. J. Fletcher, J. L. Fleg, J. N. Myers, and M. J. Sullivan
Exercise and Heart Failure: A Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention
Circulation, March 4, 2003; 107(8): 1210 - 1225.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
C. C. Lang, D. B. Chomsky, J. Butler, S. Kapoor, and J. R. Wilson
Prostaglandin production contributes to exercise-induced vasodilation in heart failure
J Appl Physiol, December 1, 1997; 83(6): 1933 - 1940.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Guazzi, G. Marenzi, M. Alimento, M. Contini, and P. Agostoni
Improvement of Alveolar–Capillary Membrane Diffusing Capacity With Enalapril in Chronic Heart Failure and Counteracting Effect of Aspirin
Circulation, April 1, 1997; 95(7): 1930 - 1936.
[Abstract] [Full Text]

Home page
 CirculationHome page
J. R. Wilson
Exercise Intolerance in Heart Failure : Importance of Skeletal Muscle
Circulation, January 15, 1995; 91(2): 559 - 561.
[Full Text]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1985 by the American College of Cardiology Foundation.